Lara Magro

1.2k total citations
21 papers, 774 citations indexed

About

Lara Magro is a scholar working on Toxicology, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lara Magro has authored 21 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Toxicology, 6 papers in Geriatrics and Gerontology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lara Magro's work include Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Drug-Induced Adverse Reactions (4 papers). Lara Magro is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Drug-Induced Adverse Reactions (4 papers). Lara Magro collaborates with scholars based in Italy, Netherlands and India. Lara Magro's co-authors include Ugo Moretti, Roberto Leone, Stefania Benvenuti, Federica Pellati, Michele Melegari, Anita Conforti, Domenico Motola, Roberto Leone, Roberto Leone and Paola Maria Cutroneo and has published in prestigious journals such as Frontiers in Pharmacology, Journal of Pharmaceutical and Biomedical Analysis and Drug Safety.

In The Last Decade

Lara Magro

16 papers receiving 729 citations

Peers

Countries citing papers authored by Lara Magro

Since Specialization

Citations

This map shows the geographic impact of Lara Magro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Magro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Magro more than expected).

Fields of papers citing papers by Lara Magro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Magro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Magro. The network helps show where Lara Magro may publish in the future.

Co-authorship network of co-authors of Lara Magro

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Magro. A scholar is included among the top collaborators of Lara Magro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Magro. Lara Magro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries 2024 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Linda Härmark, (unknown), Anita Conforti, (unknown), Lara Magro, Ugo Moretti	3
2	Assessment of educational intervention impact on improving pharmacovigilance knowledge among health care providers: A study from different hospitals in tanzania 2023 ·(unknown), Hadija Semvua, (unknown), (unknown), (unknown), Ugo Moretti, (unknown), (unknown), (unknown), Mauro Venegoni, (unknown), Blandina T. Mmbaga, Adam M. Fimbo, Lara Magro	2
3	Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database 2021 ·Frontiers in Pharmacology ·Lara Magro, Elena Arzenton, Roberto Leone, (unknown), (unknown), (unknown), (unknown), Ugo Moretti	36
4	What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects 2018 ·Drug Safety ·(unknown), Leàn Rolfes, Andries S. Koster, Lara Magro, Gurumurthy Parthasarathi, (unknown), Tim Schutte, Daisuke Tanaka, Eugène van Puijenbroek, Linda Härmark	50
5	Non-traumatic Haemorrhagic Adverse Events: A Cross-sectional Study in Emergency Departments 2018 ·Journal of Clinical Toxicology ·Lara Magro, (unknown), Mauro Venegoni, (unknown), Giorgio Ricci, Ugo Moretti, Chiara Bovo, Roberto Leone	1
6	Analisi critica dei dati prescrittivi italiani. 2015 ·Roberto Leone, Lara Magro	1
7	Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 2014 ·Expert Opinion on Drug Safety ·Elisabetta Parretta, Concetta Rafaniello, Lara Magro, (unknown), Liberata Sportiello, Carmen Ferrajolo, Annamaria Mascolo, Maurizio Sessa, Francesco Rossi, Annalisa Capuano	31
8	Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study 2013 ·Drug Safety ·Roberto Leone, Ugo Moretti, (unknown), Anita Conforti, Lara Magro, (unknown), Giampaolo Velo	40
9	Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions 2011 ·Expert Opinion on Drug Safety ·Lara Magro, Ugo Moretti, Roberto Leone	196
10	A pilot prospective observational hospital study on adverse drug reactions due to medication errors 2011 ·Roberto Leone, Lara Magro, (unknown), Pietro Minuz, (unknown), (unknown), Sara Bonafini, Giampaolo Velo	0
11	Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions 2010 ·Drug Safety ·Roberto Leone, Lara Magro, Ugo Moretti, Paola Maria Cutroneo, (unknown), Domenico Motola, Marco Tuccori, Anita Conforti	68
12	Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents 2009 ·European Journal of Clinical Pharmacology ·Carlo Piccinni, (unknown), Elisabetta Poluzzi, Domenico Motola, Lara Magro, Ugo Moretti, Anita Conforti, Nicola Montanaro	25
13	Haematological reactions by vaccines: data from the Italian spontaneous reporting system 2009 ·Anita Conforti, Lara Magro, (unknown), (unknown), Carmela Santuccio, Mauro Venegoni, Ugo Moretti, Roberto Leone, Giampaolo Velo	0
14	Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database 2008 ·Drug Safety ·G. P. Velo, Ugo Moretti, Anita Conforti, Lara Magro, Roberto Leone, (unknown), Marco Tuccori, Paola Maria Cutroneo, Domenico Motola	0
15	Identification of severe potential drug-drug interactions using an Italian general-practitioner database 2007 ·European Journal of Clinical Pharmacology ·Lara Magro, Anita Conforti, Francesco Del Zotti, Roberto Leone, (unknown), (unknown), (unknown), (unknown), Ugo Moretti	31
16	Use and safety profile of antiepileptic drugs in Italy 2007 ·European Journal of Clinical Pharmacology ·(unknown), Ugo Moretti, (unknown), Lara Magro, (unknown), Domenico Motola, (unknown), Francesco Salvo, G. P. Velo	17
17	The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate 2007 ·Drug Safety ·G. P. Velo, Domenico Motola, (unknown), Lara Magro, (unknown), Alberto Vaccheri, Anita Conforti, Nicola Montanaro	0
18	Fluvastatin and Hepatic Reactions 2006 ·Drug Safety ·Anita Conforti, Lara Magro, Ugo Moretti, (unknown), Domenico Motola, Francesco Salvo, (unknown), Roberto Leone	15
19	Drug-Related Deaths: Analysis of an Italian Spontaneous Reporting Database 2006 ·Drug Safety ·Roberto Leone, (unknown), Mauro Venegoni, Achille P. Caputi, Alessandro Conforti, Lara Magro, (unknown), Alfredo Cocci, (unknown), G. P. Velo	4
20	Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Federica Pellati, Stefania Benvenuti, Lara Magro, Michele Melegari, (unknown)	254

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact